Price (90d)
No price history yet — the daily price refresh runs once a day.
Signal Score (90d)
127Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $33.59M | $-47.12M | $-1.05 |
| 2024 | $28.05M | $-46.89M | $-1.08 |
| 2023 | $22.52M | $-52.47M | $-1.22 |
| 2022 | $17.13M | $-60.81M | $-1.43 |
| 2021 | $23.23M | $-73.52M | $-1.88 |
Social Signal Score
Earnings
Fri, Nov 6(in 3 months)
Consensus estimate $-0.19 per share
Typical surprise -3.8% (median, so one quarter with a near-zero estimate can't distort it)
- Fri, Aug 7$-0.27 vs $-0.24miss
- Wed, May 13$-0.31 vs $-0.25miss
- Thu, Mar 12$-0.28 vs $-0.23miss
- Fri, Nov 7$-0.26 vs $-0.26beat
- Tue, Aug 12$-0.27 vs $-0.26miss
- Fri, May 9$-0.26 vs $-0.27beat
Estimates and results for RPID via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Valuation
RPIDhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Mentions (1)
- Newszacks.com·3d ago·Positive
Rapid Micro Biosystems (RPID) Upgraded to Buy: What Does It Mean for the Stock? Rapid Micro Biosystems (RPID) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
View source ↗